Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Grigg

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Organic Chemistry|October 11, 2008
Regioselective synthesis of N-aminoisoindolones and mono-N- and di-N,N'-substituted phthalazones utilizing hydrazine nucleophiles in a palladium-catalyzed three-component cascade processRonald Grigg, Visuvanathar Sridharan, Mufakhrul Shah, et al.
Molecular Pharmacology|July 9, 2011
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1Joan S Lewis-Wambi, Helen Kim, Ramona Curpan, et al.
The Biochemical Journal|October 10, 2015
Histone deacetylase 3 indirectly modulates tubulin acetylationTravis Bacon, Caroline Seiler, Marcin Wolny, et al.
Arthritis and Rheumatism|September 29, 2011
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patientsJustin Gillespie, Sinisa Savic, Chi Wong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 1, 2025
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agentsJason H Gill, Jonathan D Sellars, Paul G Waddell, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 3, 2013
Carbophilic 3-component cascades: access to complex bioactive cyclopropyl diindolylmethanesNigel M Groome, Elghareeb E Elboray, Martyn W Inman, et al.
Journal of Medicinal Chemistry|August 20, 2004
Synthesis of novel rhinacanthins and related anticancer naphthoquinone estersNgampong Kongkathip, Suwaporn Luangkamin, Boonsong Kongkathip, et al.
Chemical Communications (Cambridge, England)|February 7, 2013
Stereoselective Pd(0) catalysed five component cascade synthesis of complex Z,Z-bisallylaminesRonald Grigg, Sunisa Akkarasamiyo, Nutthawat Chuanopparat, et al.
Leukemia Research|July 24, 2012
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192Marjorie Boissinot, Martyn Inman, Aiden Hempshall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic miceRuth M O'Regan, Clodia Osipo, Eric Ariazi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Organic Chemistry|October 11, 2008
Regioselective synthesis of N-aminoisoindolones and mono-N- and di-N,N'-substituted phthalazones utilizing hydrazine nucleophiles in a palladium-catalyzed three-component cascade processRonald Grigg, Visuvanathar Sridharan, Mufakhrul Shah, et al.
Molecular Pharmacology|July 9, 2011
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1Joan S Lewis-Wambi, Helen Kim, Ramona Curpan, et al.
The Biochemical Journal|October 10, 2015
Histone deacetylase 3 indirectly modulates tubulin acetylationTravis Bacon, Caroline Seiler, Marcin Wolny, et al.
Arthritis and Rheumatism|September 29, 2011
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patientsJustin Gillespie, Sinisa Savic, Chi Wong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 1, 2025
Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agentsJason H Gill, Jonathan D Sellars, Paul G Waddell, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 3, 2013
Carbophilic 3-component cascades: access to complex bioactive cyclopropyl diindolylmethanesNigel M Groome, Elghareeb E Elboray, Martyn W Inman, et al.
Journal of Medicinal Chemistry|August 20, 2004
Synthesis of novel rhinacanthins and related anticancer naphthoquinone estersNgampong Kongkathip, Suwaporn Luangkamin, Boonsong Kongkathip, et al.
Chemical Communications (Cambridge, England)|February 7, 2013
Stereoselective Pd(0) catalysed five component cascade synthesis of complex Z,Z-bisallylaminesRonald Grigg, Sunisa Akkarasamiyo, Nutthawat Chuanopparat, et al.
Leukemia Research|July 24, 2012
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192Marjorie Boissinot, Martyn Inman, Aiden Hempshall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic miceRuth M O'Regan, Clodia Osipo, Eric Ariazi, et al.
Pageof 3